There is good evidence of an excess risk of skin cancer known as melanoma in patients with Parkinson’s disease. The protective effect of tobacco smoking on the risk for Parkinson’s disease. The relationship between the risk of Parkinson’s disease and the risk of the skin cancer may be due to a common genetic profile.
Both disease possibly through an inverse relationship with tobacco smoking. Melanoma is fast spreading skin cancer found to develop more often in people with Parkinson’s. Knowing how to spot melanoma and following preventative measures can help people with PD. Decrease their risk of developing skin cancer.
Medical experts have speculated about the relationship between Parkinson’s and the other disease for decades, with varying conclusions. But others have found an association between the two diseases regardless of levodopa treatment. Levodopa major drug used in the treatment of patients with Parkinson’s disease. However, levodopa continues to be ‘contra-indicated’ for patients with Parkinson’s disease associated with malignant melanoma.
Melanoma occurrence was significantly higher after the diagnosis of PD.
The study examined the prevalence of melanoma in those 974 patients compared with 2,922 residents without Parkinson’s. They also identified 1,544 cases of melanoma over that period and determined the 35-year risk of Parkinson’s in those patients compared with the risk in the same number of people without melanoma.
The results support an association between Parkinson’s disease and other disease, but argue against levodopa as the cause, the researchers conclude. It is likelier that common environmental, genetic or immune system abnormalities underlie both conditions in patients who have both. But more research needed to confirm and refine screening recommendations.
Meanwhile, patients with one among two diseases monitored for other to help achieve early diagnosis and treatment, and educate about the risk of developing the other illness, the researchers say.